Clinical Trial Update: Monitoring SOF/VEL in Treatment Naïve, HCV Participants With Active Infection [Phase 4]

View source ↗

Summary

Phase 4 trial update monitoring Sofosbuvir/Velpatasvir (SOF/VEL) in treatment-naïve hepatitis C patients with active infection; results completed and posted in …

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Hepatitis C
• Liver Diseases

Drugs mentioned

• Sofosbuvir/Velpatasvir (sofosbuvir/velpatasvir)

Snippet

Sponsor: Advancing Clinical Therapeutics Globally for HIV/AIDS and Other Infections | Conditions: Hepatitis C, HIV-1-infection | Phase 4 | Status: COMPLETED | Results posted: 2021-07-16